A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies

BACKGROUND: Most people with Multiple Sclerosis (pwMS) are subjected to immunomodulatory disease-modifying treatments (DMTs). As a result, immune responses to COVID-19 vaccinations could be compromised. There are few data on cellular immune responses to the use of COVID-19 vaccine boosters in pwMS u...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres, Pascual, Sancho-Saldaña, Agustín, Gil Sánchez, Anna, Peralta, Silvia, Solana, Maria José, Bakkioui, Sofian, González-Mingot, Cristina, Quibus, Laura, Ruiz-Fernández, Emilio, San Pedro-Murillo, Eduardo, Brieva, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024306/
https://www.ncbi.nlm.nih.gov/pubmed/36933032
http://dx.doi.org/10.1007/s00415-023-11575-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024306/
https://www.ncbi.nlm.nih.gov/pubmed/36933032
http://dx.doi.org/10.1007/s00415-023-11575-8

Ejemplares similares